Requires certain retailers stock nicotine replacement therapy products; establishes procedures in how nicotine replacement therapy products may be sold.
S10366 would amend New York’s Public Health Law to require most businesses that sell tobacco products to also keep at least one FDA-approved nicotine replacement therapy (NRT) product in stock and available for retail sale. The mandate applies to tobacco retailers generally, but excludes cigar shops as defined in the bill. Covered retailers would have discretion over which NRT product or products to carry, how much to stock, and whether to carry more than one type.
The bill also sets basic operational rules for these products. If a retailer sells out of its NRT stock, it would have five business days to place a new order and fourteen days to restock and resume offering the product for sale. Retailers would need to display NRT products behind the sales counter, post printed notice that NRT is available, and display the New York State Smokers’ Quitline logo, phone number, and website or a successor program. The Department of Health commissioner could further regulate the size and placement of those notices.
If enacted, the bill would create a new section of the Public Health Law and impose a statewide retail requirement on tobacco sellers, effectively turning tobacco outlets into points of access for cessation aids. It would affect tobacco retailers, distributors, and any establishment selling tobacco products, while expressly exempting cigar shops. The bill would also give the Department of Health authority to set additional display standards for required notices and quitline information.
No committee transcript or vote history is available, so there is no recorded debate or formal legislative sentiment in the materials provided. Based on the bill text and caption, the measure appears to be framed as a public health and smoking-cessation initiative rather than a punitive regulation, with a focus on increasing access to quit-smoking aids at the point of tobacco sale.
The main policy tension is likely between public health goals and retailer burden. Supporters would likely emphasize easier access to nicotine replacement therapy and stronger quitline promotion, while opponents or affected retailers may object to the stocking mandate, restocking timelines, display requirements, and compliance costs. The cigar shop exemption may also be a point of contention because it treats certain tobacco-only retailers differently from other tobacco sellers.